Archive for the ‘Ticks’ Category

Nootkatone

  (Approx 1.5 min)  Published on Aug 14, 2016
Explains potential for nootkatone to one day play a role in the fight against Lyme disease, as well as zika, chikungunya, dengue and West Nile viruses.

http://www.npr.org/2011/04/18/135468567/repelling-bugs-with-the-essence-of-grapefruit

The CDC is working on a natural insect repellent made from a chemical called nootkatone, which is found in Alaska yellow cedar trees and citrus fruit, and is nongreasy, dries quickly, and supposedly smells good.

It works against mosquitos, ticks, bed bugs, head lice and possibly other insects.

It is already an approved food additive and is classified as “Generally Considered Safe.”

It kills insects in 15 seconds by blocking receptors on insects’ nerve cells for a neurotransmitter called octopamine, which makes the insects hyperactive. Although humans don’t have octopamine receptors, scientists don’t yet know whether there’s any cross-reaction between nootkatone and adrenaline receptors.

Marc Dolan of the CDC’s vector-borne infectious diseases laboratory in Fort Collins, CO states:

“Tests so far indicate that nootkatone is highly effective as an environmental insecticide, and not just against mosquitoes. “A single application of a 2 percent solution of nootkatone will control ticks for up to 42 days at greater than 97 percent efficacy.” 

It breaks down quickly and doesn’t create a lot of soil or groundwater contamination or have a great impact on other insects such as butterflies and bees.

The CDC owns patents on nootkatone and has licensed them to two companies, one to develop a repellent, the other to work on insecticides, but it is expensive — $4,000 per kilogram for highly purified food-grade product.

https://www.youtube.com/watch?v=imG0kIX-eLc&feature=youtu.be  View video footage of an untreated finger exposed to ticks vs a finger treated with nootkatone, See more at: http://www.evolva.com/products/nootkatone/#sthash.EQwxPIx7.dpuf

Evolva received approval from the EPA for the classification of biochemical pesticide active ingredient (a subcategory of biopesticide) in early 2015.  This classification allows for a potentially expedited process for registration of nootkatone for use against pests. It will take an estimated 2-3 years of regulatory work to get nootkatone approved as an insect and tick repellent in the USA.

Antibiotic Gel Prevents LD?

http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30529-1/abstract

One thousand patients with tick bites were treated with a 10% Azithromycin antibiotic gel within 72 hours of attachment.  None developed Lyme borreliosis.  Of the control group, receiving a placebo, 7 contracted LD.

The gel has to be applied every 12 hours over three days to be effective.

While this is certainly a wonderful tool for our toolbox, consider the story of the little girl who in under six hours developed a facial palsy and the inability to walk or talk after a tick bite.  https://madisonarealymesupportgroup.com/2016/12/07/igenex-presentation/   If it were not for the fast actions of an experienced Lyme literate doctor giving her  injectable antibiotics, the outcome could have been devastating and life changing.

This demonstrates that infection can enter the central nervous system quickly and cause neurological symptoms, which if left untreated can cause damage.  I wish the study followed the people for a year, minimum.  Symptoms with Lyme (borrelia) tend to wax, wane, and migrate, often fooling people into thinking their symptoms are age-related.

Also, it’s important to note that no other infections were tested.  Powassan can be contracted in as little as 15 minutes.  https://madisonarealymesupportgroup.com/2016/02/21/powassan-virus/

TBI’s Increasing and Spreading

Tick Borne Infections (TBI’s) were tested in 9 national parks in this study.

As a patient and advocate, I wish researchers would carefully choose their wording when reporting results.  For instance the authors state:  “Ba. microti occurred at just 20% of the parks.   http://jme.oxfordjournals.org/content/early/2016/12/28/jme.tjw213.  That wording will bias people into thinking it isn’t significant, but 20% is nothing to sniff at, particularly when you are one of the 20%.  Also, that is what they discovered.  Someone else may discover something else and if time is any indicator, that number will probably rise.  I would also like to see Bartonella strains added to the pathogen list.  Interesting to note: there are 210 cases of locally acquired Zika in the Continental U.S., yet Congress is considering appropriating billions of dollars toward it.   https://www.cdc.gov/zika/intheus/maps-zika-us.html, http://www.usatoday.com/story/news/2016/01/28/who-warns-zika-spread/79451430/, http://www.usatoday.com/story/news/politics/2016/05/25/zika-funding-mired-congress/84914934/

Abstract

Tick-borne pathogens transmitted by Ixodes scapularis Say (Acari: Ixodidae), also known as the deer tick or blacklegged tick, are increasing in incidence and geographic distribution in the United States. We examined the risk of tick-borne disease exposure in 9 national parks across six Northeastern and Mid-Atlantic States and the District of Columbia in 2014 and 2015. To assess the recreational risk to park visitors, we sampled for ticks along frequently used trails and calculated the density of I. scapularis nymphs (DON) and the density of infected nymphs (DIN). We determined the nymphal infection prevalence of I. scapularis with a suite of tick-borne pathogens including Borrelia burgdorferi, Borrelia miyamotoi, Anaplasma phagocytophilum, and Babesia microti. Ixodes scapularis nymphs were found in all national park units; DON ranged from 0.40 to 13.73 nymphs per 100 m2. Borrelia burgdorferi, the causative agent of Lyme disease, was found at all sites where I. scapularis was documented; DIN with B. burgdorferi ranged from 0.06 to 5.71 nymphs per 100 m2. Borrelia miyamotoi and A. phagocytophilum were documented at 60% and 70% of the parks, respectively, while Ba. microti occurred at just 20% of the parks. Ixodes scapularis is well established across much of the Northeastern and Mid-Atlantic States, and our results are generally consistent with previous studies conducted near the areas we sampled. Newly established I. scapularis populations were documented in two locations: Washington, D.C. (Rock Creek Park) and Greene County, Virginia (Shenandoah National Park). This research demonstrates the potential risk of tick-borne pathogen exposure in national parks and can be used to educate park visitors about the importance of preventative actions to minimize tick exposure.

In the eastern United States, the blacklegged tick, Ixodes scapularis Say, is the primary vector of Borrelia burgdorferi, the causative agent of Lyme disease, which is the most commonly reported vector-borne disease in the United States (Mead 2015). Ixodes scapularis also vectors other pathogens that can cause potentially serious disease, including Borrelia miyamotoi, Anaplasma phagocytophilum, and Babesia microti (Barbour and Fish 1993, Homer et al. 2000, Jin et al. 2012, Krause et al. 2015). Established blacklegged tick populations are nearly continuous across counties in the Northeastern and North-Central United States where the majority of I. scapularis-borne disease cases are reported (Mead 2015, Eisen et al. 2016). The risk of acquiring Lyme disease is influenced by spatio-temporal variation in the density of host-seeking infected nymphs (Diuk-Wasser et al. 2012). This metric often correlates with Lyme disease incidence, though to varying degrees (Mather et al. 1996, Stafford et al. 1998, Falco et al. 1999, Pepin et al. 2012). Human behavior, including time spent in tick-infested areas or engaged in behaviors that enhance or reduce the likelihood of encounters with ticks (Orloski et al. 2000, Connally et al. 2009), also influences the likelihood of acquiring Lyme disease and may explain some of the lack of concordance between measures of density of infected host-seeking nymphs and Lyme disease incidence (Pepin et al. 2012).

Understanding where people may come into contact with infected vector-competent ticks is central to mitigating tick-borne disease risk. For example, in the Mid-Atlantic and Northeastern United States, peridomestic exposure to I. scapularis likely occurs frequently (Falco and Fish 1988, Maupin et al. 1991, Klein et al. 1996, Connally et al. 2006, Feldman et al. 2015), whereas in the North-Central United States, recreational exposures are believed to be more common than peridomestic exposures (Kitron and Kazmierczak 1997, Paskewitz et al. 2001). Regardless of geographic region, previous studies have demonstrated a risk of human exposure to infected host-seeking I. scapularis nymphs in recreational settings (Falco and Fish 1989, Schulze et al. 1992, Oliver and Howard 1998, Paskewitz et al. 2001, Han et al. 2014, Prusinski et al. 2014, Ford et al. 2015). National parks are popular recreation destinations and may represent areas of elevated acarological risk, yet one cannot adequately infer the risk of tick-borne disease for park visitors or employees from the epidemiological surveillance conducted at the county spatial scale (Eisen et al. 2013). National parks often vary ecologically from surrounding areas, and thus the density of infected ticks may differ between settings; further, human behavior within the parks may differ from behavior in surrounding communities.

In this study, we sought to characterize the acarological risk, that is, the risk of human exposure to tick-borne pathogens, in national parks in the Eastern United States. We surveyed frequently used trails in national park units across six Northeastern and Mid-Atlantic States and the District of Columbia, ranging from Maine in the north to Virginia in the south. Our collection efforts focused on the nymphal stage of I. scapularis. This stage likely poses the greatest threat of transmission of B. burgdorferi and other pathogens to humans, as peak activity of questing nymphs occurs in late spring and early summer which coincides with peak onset of human disease (Piesman 1989, Fish 1993, Falco et al. 1999, Mead 2015). Here, we describe the diversity of ticks collected by drag sampling during summer months, density of host-seeking I. scapularis nymphs, and diversity and prevalence of B. burgdorferi, B. miyamotoi, A. phagocytophilum, and Ba. microti infection in I. scapularis nymphs.

Bb Endemic in Ticks & Hosts Outer Banks of North Carolina

http://doi.org/10.1111/zph.12302

Abstract

The spirochaete Borrelia burgdorferi associated with Lyme disease was detected in questing ticks and rodents during a period of 18 years, 1991–2009, at five locations on the Outer Banks of North Carolina. The black-legged tick Ixodes scapularis was collected at varied intervals between 1991 and 2009 and examined for B. burgdorferi. The white-footed mouse Peromyscus leucopus, house mouse Mus musculus marsh rice rat Oryzomys palustris, marsh rabbit Sylvilagus palustris, eastern cottontail Sylvilagus floridanus and six-lined racerunner Cnemidophorus sexlineatus were live-trapped, and their tissues cultured to isolate spirochaetes.

Borrelia burgdorferi isolates were obtained from questing adult I. scapularis and engorged I. scapularis removed from P. leucopus, O. palustris and S. floridanus. The prevalence of B. burgdorferi infection was variable at different times and sites ranging from 7 to 14% of examined questing I. scapularis. Mitochondrial (16S) rRNA gene phylogenetic analysis from 65 adult I. scapularis identified 12 haplotypes in two major clades. Nine haplotypes were associated with northern/Midwestern I. scapularis populations and three with southern I. scapularis populations. Sixteen isolates obtained from tick hosts in 2005 were confirmed to be B. burgdorferi by amplifying and sequencing of 16S rRNA and 5S-23S intergenic spacer fragments. The sequences had 98–99% identity to B. burgdorferi sensu stricto strains B31, JD1 and M11p.

Taken together, these studies indicate that B. burgdorferi sensu stricto is endemic in questing I. scapularis and mammalian tick hosts on the Outer Banks of North Carolina.

IGeneX Presentation

Published on Dec 7, 2016

The Madison Area Lyme Support Group hosts the IGeneX Lab to present information regarding testing of tick-borne illnesses.   2 Hours long

https://madisonarealymesupportgroup.com/2016/11/01/nov-support-meeting-with-igenex-lab/

Transmission Time:  Only one study done on Mice.  At 24 hours every tick had transmitted to the mice; however, in the following video microbiologist Holly Ahern explains how this information has been inappropriately used for the widely held belief that if you pull a tick off before 24 hours you won’t get infected.  No human studies have been done and animal studies have proven that transmission can occur in under 16 hours and it occurs frequently in under 24 hours.  https://www.dovepress.com/lyme-borreliosis-a-review-of-data-on-transmission-time-after-tick-atta-peer-reviewed-article-IJGM

Bob Giguere of IGeneX states a case by Dr. Jones of a little girl who went outside to play about 8:30a.m. and came inside at 10:30 with an attached tick above her right eye.  By 2 o’clock, she had developed the facial palsy.  At the hospital she was told it couldn’t be Lyme as the tick hadn’t been attached long enough.  They offered a neuro-consult…..

By 4pm she couldn’t walk or talk.

Dr. Jones met the family in his office on a Saturday, gave her an intramuscular injection of antibiotics and within 2 hours the palsy was gone.  He continued her treatment for approximately 4 weeks.

Coincidence?

I think not.  

Do not believe what the “experts” tell you about transmission times!